Return On Assets in % of Paratek Pharmaceuticals, Inc. from Q1 2012 to Q2 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Paratek Pharmaceuticals, Inc. quarterly and annual Return On Assets history and change rate from Q1 2012 to Q2 2023.
  • Paratek Pharmaceuticals, Inc. Return On Assets for the quarter ending 30 Jun 2023 was -40%, a 18% increase year-over-year.
  • Paratek Pharmaceuticals, Inc. annual Return On Assets for 2022 was -38%, a 14% decline from 2021.
  • Paratek Pharmaceuticals, Inc. annual Return On Assets for 2021 was -34%, a 27% increase from 2020.
  • Paratek Pharmaceuticals, Inc. annual Return On Assets for 2020 was -46%, a 5.6% increase from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Paratek Pharmaceuticals, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2023 -40% +9% +18% 01 Apr 2023 30 Jun 2023
Q1 2023 -41% -8% -25% 01 Jan 2023 31 Mar 2023
Q4 2022 -38% -5% -14% 01 Oct 2022 31 Dec 2022
Q3 2022 -53% -23% -77% 01 Jul 2022 30 Sep 2022
Q2 2022 -49% -19% -61% 01 Apr 2022 30 Jun 2022
Q1 2022 -33% +13% +28% 01 Jan 2022 31 Mar 2022
Q4 2021 -34% +13% +27% 01 Oct 2021 31 Dec 2021
Q3 2021 -30% +14% +32% 01 Jul 2021 30 Sep 2021
Q2 2021 -31% +15% +33% 01 Apr 2021 30 Jun 2021
Q1 2021 -46% +2% +3.8% 01 Jan 2021 31 Mar 2021
Q4 2020 -46% +3% +5.6% 01 Oct 2020 31 Dec 2020
Q3 2020 -43% +2% +3.6% 01 Jul 2020 30 Sep 2020
Q2 2020 -46% -3% -8.2% 01 Apr 2020 30 Jun 2020
Q1 2020 -48% -8% -21% 01 Jan 2020 31 Mar 2020
Q4 2019 -49% -9% -24% 01 Oct 2019 31 Dec 2019
Q3 2019 -45% -1% -1.2% 01 Jul 2019 30 Sep 2019
Q2 2019 -42% +5% +10% 01 Apr 2019 30 Jun 2019
Q1 2019 -39% +11% +22% 01 Jan 2019 31 Mar 2019
Q4 2018 -40% +14% +26% 01 Oct 2018 31 Dec 2018
Q3 2018 -45% +14% +24% 01 Jul 2018 30 Sep 2018
Q2 2018 -47% +17% +27% 01 Apr 2018 30 Jun 2018
Q1 2018 -50% +25% +33% 01 Jan 2018 31 Mar 2018
Q4 2017 -54% +27% +34% 01 Oct 2017 31 Dec 2017
Q3 2017 -59% +17% +22% 01 Jul 2017 30 Sep 2017
Q2 2017 -64% +8% +11% 01 Apr 2017 30 Jun 2017
Q1 2017 -75% -13% -21% 01 Jan 2017 31 Mar 2017
Q4 2016 -81% -31% -62% 01 Oct 2016 31 Dec 2016
Q3 2016 -76% -30% -65% 01 Jul 2016 30 Sep 2016
Q2 2016 -72% -32% -80% 01 Apr 2016 30 Jun 2016
Q1 2016 -62% -25% -65% 01 Jan 2016 31 Mar 2016
Q4 2015 -50% -23% -84% 01 Oct 2015 31 Dec 2015
Q3 2015 -46% -14% -44% 01 Jul 2015 30 Sep 2015
Q2 2015 -40% -12% -43% 01 Apr 2015 30 Jun 2015
Q1 2015 -37% -6% -20% 01 Jan 2015 31 Mar 2015
Q4 2014 -27% +17% +38% 01 Oct 2014 31 Dec 2014
Q3 2014 -32% +1% +3% 01 Jul 2014 30 Sep 2014
Q2 2014 -28% -8% -37% 01 Apr 2014 30 Jun 2014
Q1 2014 -31% -13% -75% 01 Jan 2014 31 Mar 2014
Q4 2013 -44% -31% -234% 01 Oct 2013 31 Dec 2013
Q3 2013 -33% -33% -16542% 01 Jul 2013 30 Sep 2013
Q2 2013 -20% -7% -48% 01 Apr 2013 30 Jun 2013
Q1 2013 -18% -7% -62% 01 Jan 2013 31 Mar 2013
Q4 2012 -13% 01 Oct 2012 31 Dec 2012
Q3 2012 0% 01 Jul 2012 30 Sep 2012
Q2 2012 -14% 01 Apr 2012 30 Jun 2012
Q1 2012 -11% 01 Jan 2012 31 Mar 2012

Paratek Pharmaceuticals, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2022 -38% -5% -14% 01 Jan 2022 31 Dec 2022
2021 -34% +13% +27% 01 Jan 2021 31 Dec 2021
2020 -46% +3% +5.6% 01 Jan 2020 31 Dec 2020
2019 -49% -9% -24% 01 Jan 2019 31 Dec 2019
2018 -40% +14% +26% 01 Jan 2018 31 Dec 2018
2017 -54% +27% +34% 01 Jan 2017 31 Dec 2017
2016 -81% -31% -62% 01 Jan 2016 31 Dec 2016
2015 -50% -23% -84% 01 Jan 2015 31 Dec 2015
2014 -27% -20% -265% 01 Jan 2014 31 Dec 2014
2013 -7% +6% +43% 01 Jan 2013 31 Dec 2013
2012 -13% 01 Jan 2012 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.